Premium
Apathy as a feature of prodromal Alzheimer's disease: an FDG‐PET ADNI study
Author(s) -
Delrieu Julien,
Desmidt Thomas,
Camus Vincent,
Sourdet Sandrine,
BoutoleauBretonnière Claire,
Mullin Emmanuel,
Vellas Bruno,
Payoux Pierre,
Lebouvier Thibaud
Publication year - 2015
Publication title -
international journal of geriatric psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 129
eISSN - 1099-1166
pISSN - 0885-6230
DOI - 10.1002/gps.4161
Subject(s) - apathy , psychology , atrophy , alzheimer's disease , alzheimer's disease neuroimaging initiative , neuroimaging , positron emission tomography , dementia , psychiatry , posterior cingulate , medicine , cognition , disease , neuroscience
Objective The goal of this study is to evaluate brain metabolism in mild cognitive impairment (MCI) patients with and without apathy (as determined by the Neuropsychiatric Inventory Questionnaire). Methods Baseline data from 65 MCI participants (11 with apathy and 54 without) from the Alzheimer's Disease (AD) Neuroimaging Initiative study were analyzed. All participants underwent a comprehensive cognitive and neuropsychiatric assessment, volumetric MRI and measures of cerebral glucose metabolism applying 18 F‐fluorodeoxyglucose positron emission tomography at baseline. The presence of apathy at baseline was determined by the Neuropsychiatric Inventory Questionnaire. Results There was no difference between apathy and apathy‐free MCI patients regarding cognitive assessment and neuropsychiatric measures when apathy‐specific items were removed. Cerebrovascular disease load and cerebral atrophy were equivalent in both groups. Compared with the apathy‐free MCI patients, MCI patients with apathy had significantly decreased metabolism in the posterior cingulate cortex. Conclusion The presence of apathy in MCI patients is associated with AD‐specific pattern of brain metabolic defect. These results could suggest that apathy belongs to the spectrum of prodromal AD symptoms. Copyright © 2014 John Wiley & Sons, Ltd.